InMode expands women’s wellness portfolio with acquisition of Viveve patents
Media release 27 July 2026 InMode expands women’s wellness portfolio with acquisition of Viveve patents InMode has further cemented its position as a leader in women’s wellness, purchasing the in...
AKE FOREST, Calif., Nov. 10, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to share a groundbreaking peer reviewed study,...
InMode Announces US Patent for Fractional RF (Morpheus8)
We are extremely pleased to announce that the US Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morphues8 full body fractional radiofrequency (RF) technology.
InMode introduces Morpheus8 body with multi pulse BURST technology
INMODE INTRODUCES MORPHEUS 8 BODY WITH MULTI-PULSE BURST TECHNOLOGY. Sydney, Australia, October 23rd, 2020 - InMode Ltd (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical te...
InMode Launches Morpheus8 Platform and Morpheus8 Body Fractional Technology
Sydney, Australia, September 17th, 2020 - InMode Ltd (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce the expansion of the unique Morp...
InMode supports the Aesthetic Industry. Message from Dennis Cronje, Managing Director
INMODE STEPS UP TO ASSIST THE AESTHETIC INDUSTRY IN CONJUNCTION WITH THE GOVERNMENT’S ECONOMIC STIMULUS PACKAGE. InMode Australia is committed to the health and well-being of our employees and the...